About 7 results found for searched term "66-81-9" (0.054 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2165 | WAY-362450 (Turofexorate isopropyl) | Farnesoid X Receptor |
| XL335; FXR-450 | ||
| WAY-362450 (Turofexorate isopropyl; XL335) is a potent, selective, and orally bioavailable FXR agonist with EC50 of 4 nM. | ||
| M4879 | Cycloheximide | DNA/RNA Synthesis |
| Naramycin A; Actidione; CHX; FT 3422-2; NM-MCD 80 | ||
| Cycloheximide is an inhibitor of protein biosynthesis in eukaryotic organisms, with IC50 of 532.5 nM. | ||
| M7295 | SID 26681509 | Others |
| SID 26681509 is a cathepsin L inhibitor. | ||
| M14308 | SID 26681509 quarterhydrate | Cathepsin |
| SID 26681509 quarterhydrate is a potent, reversible, competitive, and selective inhibitor of human cathepsin L with an IC50 of 56 nM. | ||
| M24577 | Namilumab | CSF-1R (c-Fms) |
| AMG-203; Anti-Human CSF2 Recombinant Antibody | ||
| Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis. | ||
| M49733 | AChE/BACE1/GSK3β-IN-1 | Gamma-secretase/Beta-secretase |
| AChE/BACE1/GSK3β-IN-1 is an orally active triple inhibitor of AChE/BACE1/GSK3β. | ||
| M52813 | EGF-R (661-681) T669 Peptide | p38 MAPK |
| EGF-R (661-681) T669 Peptide is a MAPK substrate that can used to measure MAPK catalytic activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
